This graphic depicts a new ultrasensitive biosensor that could open up new opportunities for early detection of cancer and “personalized medicine” tailored to the specific biochemistry of individual patients. The device, called a flexure-FET biosensor, could be several hundred times more sensitive than other biosensors. (Purdue University image)